ClinicalTrials.govpublic full text
The Efficacy and Safety of Third-generation TKIs Combined With Azacitidine and Bcl-2 Inhibitor in Patients With CML-MBP
chronic myeloid leukemia, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 905988
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.